Evaluates the impact of rituximab and prednisone on renal adverse events in patients undergoing ICI therapy, suggesting potential improved management strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Seshadri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: